Psychoneuroendocrinology of depression. Growth hormone
- PMID: 9670229
- DOI: 10.1016/s0193-953x(05)70008-3
Psychoneuroendocrinology of depression. Growth hormone
Abstract
The release of growth hormone (GH) from the anterior pituitary is regulated by hypothalamic peptides especially GH-releasing hormone (GHRH) and somatostatin, which in turn are controlled by classic neurotransmitters such as noradrenaline, dopamine, and acetylcholine, as well as negative feedback from GH and insulin-like growth factor-1. There has been extensive investigation of this axis in patients with depression. The most consistently reported abnormality is in noradrenergic-mediated GH release, which probably occurs via GHRH containing neurones. ACh-induced GH release through the somatostatin system, GABA, and also GHRH-stimulated release are reported as abnormal by some researchers.
Similar articles
-
Epilepsy, depression, and growth hormone.Epilepsy Behav. 2019 May;94:297-300. doi: 10.1016/j.yebeh.2019.01.022. Epub 2019 Feb 14. Epilepsy Behav. 2019. PMID: 30773449 Free PMC article. Review.
-
Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis.Psychiatr Clin North Am. 1998 Jun;21(2):293-307. doi: 10.1016/s0193-953x(05)70006-x. Psychiatr Clin North Am. 1998. PMID: 9670227 Review.
-
Evidence for integrity of the growth hormone/insulin-like growth factor-1 axis in patients with severe head trauma during rehabilitation.Metabolism. 2002 Oct;51(10):1363-9. doi: 10.1053/meta.2002.34714. Metabolism. 2002. PMID: 12370860 Clinical Trial.
-
The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants.J Neuroendocrinol. 1999 Jul;11(7):521-8. doi: 10.1046/j.1365-2826.1999.00353.x. J Neuroendocrinol. 1999. PMID: 10444309
-
Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.J Clin Endocrinol Metab. 2000 Mar;85(3):1310-5. doi: 10.1210/jcem.85.3.6531. J Clin Endocrinol Metab. 2000. PMID: 10720081 Clinical Trial.
Cited by
-
The Four-Cluster Spectrum of Mind-Body Interrelationships: An Integrative Model.Front Psychiatry. 2019 Mar 1;10:39. doi: 10.3389/fpsyt.2019.00039. eCollection 2019. Front Psychiatry. 2019. PMID: 30881314 Free PMC article.
-
Characteristics, correlates, and outcomes of childhood and adolescent depressive disorders.Dialogues Clin Neurosci. 2009;11(1):45-62. doi: 10.31887/DCNS.2009.11.1/urao. Dialogues Clin Neurosci. 2009. PMID: 19432387 Free PMC article. Review.
-
Biomarkers of intergenerational risk for depression: a review of mechanisms in longitudinal high-risk (LHR) studies.J Affect Disord. 2015 Apr 1;175:494-506. doi: 10.1016/j.jad.2015.01.038. Epub 2015 Jan 24. J Affect Disord. 2015. PMID: 25687188 Free PMC article. Review.
-
Endocrine disturbances in depression.J Endocrinol Invest. 2005 Jan;28(1):89-99. doi: 10.1007/BF03345535. J Endocrinol Invest. 2005. PMID: 15816377 Review.
-
Epilepsy, depression, and growth hormone.Epilepsy Behav. 2019 May;94:297-300. doi: 10.1016/j.yebeh.2019.01.022. Epub 2019 Feb 14. Epilepsy Behav. 2019. PMID: 30773449 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical